- The Accuracy of Frozen Section Diagnosis of Gynecologic Tumors
-
Kim MS, Nam KH, Kim DW
- KMID: 2245054
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):56-60.
In a retrospective study to determine the accuracy of frozen section diagnosis in gynecologic tumors, the results of consecutive frozen section diagnosis of 73 gynecologic tumors from May 1993 through... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Krukenberg Tumors
-
Park CH, Kim YH, Lee SK, Rew JH, Park JY, Hong SY, Ahn HS
- KMID: 2245056
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):68-75.
Krukenberg tumor of the ovary, originally described by Krukenberg as "Fibrosarcoma ovarii mucocellulare carcinomatodes", characterized as an infiltrative mucinous carcinoma of predominant signet-ring cell type, almost metastasize from gastrointestinal tract,... -
- CITED
-
- Close
- SHARE
-
- Close
- Sonographic Evaluation of the Cervical Volume Change Before and After Neoadjuvant Chemotheraphy in the Cervical Carcinoma as a Objective Method
-
Yoo JB, Roh JS, Kim KT, Cho SH, Moon H, Hwang YY
- KMID: 2245055
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):61-67.
The ultrasound is easily available and noninvasive diagnostic method. The purpose of this study was to assess the potential role of ultrasound in evaluating the response of cervical carcinoma to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Neoadjuvant PI(Cisplatin, Ifosfamide) and PAIB(Cisplatin, Adriamycin, Ifosfamide, Bleomycin) in the Cervical Cancer
-
Kim JH, Weon JY, Jeon CS, You BJ, Lee YS, Park IS
- KMID: 2245050
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):23-28.
For cervical cancer, the combination chemotherapy could increase the trial of radical hysterectomy due to reduction in tumor volume even in advanced stage and help to decrease corrected dose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of CA 125 Antigen to Predict Suvival of Patients with Epithelial Ovarian Cancer
-
Kim KT, Moon H, Hwang YY
- KMID: 2245049
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):14-22.
The prognostic value of serum CA 125 measurements was assessed in 68 patients with epithelial ovarian cancer. All patients received a minimum of two courses of cisplatin at the Department... -
- CITED
-
- Close
- SHARE
-
- Close
- Cisplatin/cyclophoshpamide(CP) Combination Chemotherapy with or without Adriamycin in Advanced Epithelial Ovarian Cancer
-
Kang SB, Ryu SY, Kim JW, Koh CW, Pakr NH, Song YS, Lee HP
- KMID: 2245052
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):37-43.
Cyclophosphamide, adriamycin, and cisplatin(CAP) combination chemotherapy improved the response rate in the treatment of advanced epithelial ovarian cancer, and it has been the gold standard. However, adriamycin is a rather... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical and Statistical Study in 78 Cases of Ovarian Cancer
-
Park IS, Lee YS, Hwang SG, Lee MS
- KMID: 2245051
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):29-36.
Clinical and pathological studies were carried out on 78 patients of ovarian cancer from January 1985 to March 1991. The results are as follows : l. Among 78 patients of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Study of DNA Ploidy and Proliferating Cell Nuclear Antigen(PCNA) as a Prognostic Factor in Uterine Cervical Cancer
-
Shim IG, Nam KH, Lee HH, Jin SY, Lee KH
- KMID: 2245053
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):44-55.
OBJECTIVE: The objective of this study were to clarify the significance of PCNA and DNA ploidy as a possible parameter of the prognosis in squamous cell carcinoma of the uterine... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of Interleukin-2(IL-2), Interleukin-6(IL-6), and Tumor Necrosis Factor-a(TNF-a) in the Ascites of Ovarian Cancer
-
Kim YO, Kim KT, Yoo JB, Cho SH, Hwang YY, Moon H, Lee JA
- KMID: 2245048
- Korean J Gynecol Oncol Colposc.
- 1996 Mar;7(1):1-13.
Previous studies have shown that the cancer cell lines secrete multiple cytokines, such as macrophage colony-stimulating factor(M-CSF), granulocyte-macrophage colony stimulating factor(GM-CSF), interleukin-l(IL-1), interleukin-2(IL-2), interleukin-6(IL-6), and tumor necrosis factor-alpha(TNF-alpha). We evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
